Skip to main content

The latest news &
insights from ArteraAI

View company news, research articles, publications, and industry thought leadership currently making headlines in the cancer treatment space.

Show All
Resources
Upcoming & Past Events
Press & Media
Publications & Presentations
Videos
Insights
Upcoming & Past Events

SUO 24th Annual Meeting

November 28 – December 1, 2023 Washington, DC

Press & Media

AI Models in Prostate Cancer Tackle Treatment Disparities Facing...

In an interview with Peers & Perspectives in Oncology, Rana McKay, MD, explains how an AI model can affect the disparitie [...]

Videos

Multimodal AI Informing Treatment Decisions in Advanced Prostate Cancer...

Alicia Morgans interviews Gerhardt Attard about groundbreaking research presented at ESMO 2023, utilizing the STAMPEDE data s [...]

Resources

Mind the Gap

While all men are at risk for prostate cancer, there are disproportionate gaps in treatment, research, clinical trials and mo [...]

Upcoming & Past Events

LUGPA Annual Meeting

ArteraAI will be attending LUGPA Annual Meeting,  November 2nd - 4th, 2023, Booth #110,  Lake Buena Vista, Florida

Resources

Clinical Validation of a Multimodal Artificial Intelligence Prognostic Model...

Artera has developed multimodal AI (MMAI)-enabled predictive and prognostic biomarkers for patients with prostate cancer usin [...]

Press & Media

Dr. Parker and Dr. Attard on the utility of...

In this video, Charles Parker, MD, and Gerhardt Attard, MD, PhD, discuss notable findings from the study “External validation [...]

Press & Media

Using AI to Optimize Therapeutic Choices and QOL in...

In an interview with Peers and Perspectives in Oncology, Tim Showalter, MD, MPH, vice president of clinical development at Ar [...]

Load More